Aug 12 (Reuters) - AN2 Therapeutics Inc ( ANTX ):
* BML INVESTMENT PARTNERS, L.P. REPORTS 14.2% PASSIVE STAKE
IN
AN2 THERAPEUTICS AS OF AUGUST 9, 2024- SEC FILING
Source text for Eikon:
Further company coverage: